3646 results for «585»

Filter By

3646 results

CABG vs. PCI - Multivessel disease

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to find out more about the guidelines in revascularisation for multivessel disease, simplification of multivessel disease PCI using physiological guidance, and much more!

CABG vs. PCI - Multivessel disease

All you need to know on physiology: a 2023 update

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, listen to William Wijns discuss the following physiology topics: long-term data on PCI deferral, update on new "negative" studies, low adoption in daily practice, and computational image-based physiology.    

All you need to know on physiology: a 2023 update

Challenging and complication cases

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to learn how to deal with post-infarction ventricular rupture, an unusual post-CABG complication, a left main complication with the LACOSTE technique, the entrapment of a knotted catheter in the radial artery during primary PCI, and much more!

Challenging and complication cases

GulfPCR-GIM 2022 - Closing Ceremony

15 Dec 2022 – From GulfPCR-GIM 2022

Listen to the Course Directors thank all the participants and take stock of this 2022 edition, insisting in particular on the role of imaging, which must not however make us forget the basics of interventional cardiology, before attending the prize-giving ceremony for the best clinical cases...

GulfPCR-GIM 2022 - Closing Ceremony

Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease (WARRIOR)

31 Mar 2025

Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.

The manuscript for this trial has not been published and all assumptions are based upon the presentation.

Nicola Ryan

Author

Nicola Ryan
Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART
Didn’t find what you were looking for?